|
SAMD12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.747870E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.476200E-02 |
| Normal-vs-Stage2 |
3.385800E-01 |
| Normal-vs-Stage3 |
6.780600E-01 |
| Normal-vs-Stage4 |
3.444600E-01 |
| Stage1-vs-Stage2 |
9.826000E-01 |
| Stage1-vs-Stage3 |
3.519000E-01 |
| Stage1-vs-Stage4 |
9.379600E-01 |
| Stage2-vs-Stage3 |
5.612600E-01 |
| Stage2-vs-Stage4 |
9.481400E-01 |
| Stage3-vs-Stage4 |
6.660800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.367600E-02 |
| Normal-vs-AfricanAmerican |
6.915600E-02 |
| Normal-vs-Asian |
7.453000E-01 |
| Caucasian-vs-AfricanAmerican |
9.371600E-01 |
| Caucasian-vs-Asian |
6.026400E-01 |
| AfricanAmerican-vs-Asian |
5.898600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.738100E-02 |
| Normal-vs-Female |
1.590270E-02 |
| Male-vs-Female |
3.206400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.821600E-01 |
| Normal-vs-Extreme_Weight |
1.529450E-01 |
| Normal-vs-Obese |
5.804900E-03 |
| Normal-vs-Extreme_Obese |
7.554000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.012800E-01 |
| Normal_Weight-vs-Obese |
6.694000E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.853800E-01 |
| Extreme_Weight-vs-Obese |
8.927900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.477800E-01 |
| Obese-vs-Extreme_Obese |
2.383600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.850000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.555600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.248030E-01 |
| Normal-vs-Age(81-100Yrs) |
5.461400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.723800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.842150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.809600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.807600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.680200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.928180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.199970E-03 |
| Normal-VS-Type2 PRCC |
3.521000E-01 |
| Normal-VS-KIRP CIMP |
4.480300E-02 |
| Normal-VS-Unclassified PRCC |
1.039850E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.0020000000297E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.684000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.341800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.416300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.675870E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.384800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.333600E-01 |
| Normal-vs-N1 |
1.709640E-01 |
| Normal-vs-N2 |
5.328200E-02 |
| N0-vs-N1 |
8.871500E-02 |
| N0-vs-N2 |
4.253600E-02 |
| N1-vs-N2 |
4.776800E-01 |
|
|
